The influential National Comprehensive Cancer Network has reversed a long-standing recommendation about low-risk prostate cancer and active surveillance.
Medscape Medical News
The influential National Comprehensive Cancer Network has reversed a long-standing recommendation about low-risk prostate cancer and active surveillance.
Medscape Medical News